These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14724576)

  • 1. Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells.
    Wang X; Ling MT; Guan XY; Tsao SW; Cheung HW; Lee DT; Wong YC
    Oncogene; 2004 Jan; 23(2):474-82. PubMed ID: 14724576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosome-Mediated Transfer of ALDH2 in Nasopharyngeal Carcinoma Cells Confers Increased Resistance to Paclitaxel Treatment.
    Yan J; Wu L; Zheng M; Pan F
    Discov Med; 2024 Jun; 36(185):1210-1220. PubMed ID: 38926107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of autophagy-associated protein increased acquired radio-resistance bladder cancer cells sensitivity to taxol.
    Ma X; Mao G; Chang R; Wang F; Zhang X; Kong Z
    Int J Radiat Biol; 2021; 97(4):507-516. PubMed ID: 33443463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of a novel antiapoptotic factor: role of inhibitor of differentiation or DNA binding (Id-1) in anticancer drug-induced apoptosis.
    Zhang X; Ling MT; Wong YC; Wang X
    Cancer Sci; 2007 Mar; 98(3):308-14. PubMed ID: 17214747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nature of the modification at position 37 of tRNAPhe correlates with acquired taxol resistance.
    Pan Y; Yan TM; Wang JR; Jiang ZH
    Nucleic Acids Res; 2021 Jan; 49(1):38-52. PubMed ID: 33290562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breaking malignant nuclei as a non-mitotic mechanism of taxol/paclitaxel.
    Smith ER; Xu XX
    J Cancer Biol; 2021; 2(4):86-93. PubMed ID: 35048083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing the malignancy and drug resistance of cancer cells from their membrane resealing response.
    Hui TH; Zhou ZL; Fong HW; Ngan RK; Lee TY; Au JS; Ngan AH; Yip TT; Lin Y
    Sci Rep; 2016 May; 6():26692. PubMed ID: 27225309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twist Around the Clock!
    Lejay A; Ohana M
    Eur J Vasc Endovasc Surg; 2023 Dec; 66(6):839. PubMed ID: 37714291
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeting MYCN in neuroblastoma by BET bromodomain inhibition.
    Puissant A; Frumm SM; Alexe G; Bassil CF; Qi J; Chanthery YH; Nekritz EA; Zeid R; Gustafson WC; Greninger P; Garnett MJ; McDermott U; Benes CH; Kung AL; Weiss WA; Bradner JE; Stegmaier K
    Cancer Discov; 2013 Mar; 3(3):308-23. PubMed ID: 23430699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of TWIST and E-cadherin expression in the metastatic progression of prostatic cancer.
    Yuen HF; Chua CW; Chan YP; Wong YC; Wang X; Chan KW
    Histopathology; 2007 Apr; 50(5):648-58. PubMed ID: 17394502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trefoil factor 1 suppresses stemness and enhances chemosensitivity of pancreatic cancer.
    Yamaguchi J; Kokuryo T; Yokoyama Y; Oishi S; Sunagawa M; Mizuno T; Onoe S; Watanabe N; Ogura A; Ebata T
    Cancer Med; 2024 Jun; 13(11):e7395. PubMed ID: 38872370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between Wnt/β-catenin signaling pathway and EMT pathway mediates the mechanism of sunitinib resistance in renal cell carcinoma.
    Cai F; Li J; Zhang Y; Huang S; Liu W; Zhuo W; Qiu C
    BMC Cancer; 2024 Feb; 24(1):175. PubMed ID: 38317072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response.
    Ebrahimi N; Manavi MS; Faghihkhorasani F; Fakhr SS; Baei FJ; Khorasani FF; Zare MM; Far NP; Rezaei-Tazangi F; Ren J; Reiter RJ; Nabavi N; Aref AR; Chen C; Ertas YN; Lu Q
    Cancer Metastasis Rev; 2024 Mar; 43(1):457-479. PubMed ID: 38227149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shake It Up Baby Now: The Changing Focus on TWIST1 and Epithelial to Mesenchymal Transition in Cancer and Other Diseases.
    Mirjat D; Kashif M; Roberts CM
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRPM7 transactivates the FOSL1 gene through STAT3 and enhances glioma stemness.
    Guo S; Ramar V; Guo AA; Saafir T; Akpobiyeri H; Hudson B; Li J; Liu M
    Cell Mol Life Sci; 2023 Aug; 80(9):270. PubMed ID: 37642779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDC20 promotes radioresistance of prostate cancer by activating Twist1 expression.
    Yang C; Ge Y; Zang Y; Xu M; Jin L; Wang Y; Xu X; Xue B; Wang Z; Wang L
    Apoptosis; 2023 Dec; 28(11-12):1584-1595. PubMed ID: 37535214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapeutic Resistance Genes of Breast Cancer Patients - An Overview.
    Ajith AK; Subramani S; Manickam AH; Ramasamy S
    Adv Pharm Bull; 2022 Aug; 12(4):649-657. PubMed ID: 36415633
    [No Abstract]   [Full Text] [Related]  

  • 18. Crosstalk between Ca
    Kouba S; Hague F; Ahidouch A; Ouadid-Ahidouch H
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twist alters the breast tumor microenvironment via choline kinase to facilitate an aggressive phenotype.
    Vesuna F; Penet MF; Mori N; Bhujwalla ZM; Raman V
    Mol Cell Biochem; 2023 Apr; 478(4):939-948. PubMed ID: 36136285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lidocaine: A Local Anesthetic, Its Adverse Effects and Management.
    Bahar E; Yoon H
    Medicina (Kaunas); 2021 Jul; 57(8):. PubMed ID: 34440986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.